NCT05878405View on ClinicalTrials.gov

Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

June 6, 2023

Primary Completion Date

December 6, 2024

Study Completion Date

December 6, 2024

Conditions
Hematopoietic and Lymphoid System NeoplasmMalignant Solid NeoplasmStomatitis
Interventions
OTHER

Anti-inflammatory/Antimicrobial/Analgesic Aqueous Mouth Rinse

Given PO

OTHER

Methylene Blue Oral Rinse

Given PO

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05878405 - Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer | Biotech Hunter | Biotech Hunter